PN-900 CandidaGenius® C. auris screening assay

Real‑time PCR assay for the rapid and direct detection of Candida auris from non‑invasive swabs, without the need for prior culture.

Detailed Description

The PN-900 CandidaGenius® C. auris screening assay is a molecular tool designed for the qualitative detection of Candida auris DNA by real‑time PCR. This emerging fungus represents a growing challenge in the hospital setting due to its multi‑drug resistance and its ability to cause nosocomial outbreaks. This assay allows direct identification of Candida auris from samples obtained with ESwab swabs from anatomical sites such as nares, mouth/throat, perineum, bilateral axillae, and groin. One of its main advantages is that it does not require prior culture, significantly reducing the time to obtain results, which can be available in less than 1.5 hours from nucleic acid extraction. The kit employs an amplification strategy targeting the ITS (Internal Transcribed Spacer) gene, a highly conserved and specific region of the fungus, providing high specificity in identification. Additionally, it includes internal and positive controls to ensure the validity and reliability of the amplification and detection process. CandidaGenius® is compatible with multiple real‑time PCR platforms, facilitating its implementation.

Key Features

Rapid and direct detection of Candida auris without the need for culture
Results available in less than 1.5 hours
Based on ITS gene amplification
Uses non‑invasive samples (ESwabs)
Compatible with various real‑time PCR thermal cyclers
Includes internal control and positive control
For research use only (RUO)

Presentation Details

CandidaGenius® C. auris (PN-900)
Format: Kit for 50 reactions Product code: PN-900 Sample type: ESwab swabs from nares, mouth/throat, perineum, bilateral axillae, and groin Compatible instruments: LightCycler 480 II, Rotor-Gene Q, CFX96, QuantStudio 5, Mic qPCR cycler Classification: For research use only (RUO)
×

Area:

Fungus, Microbiology
Consult our experts

Google reCaptcha: Invalid site key.

Related products

Franklin by QIAGEN for Somatic Analysis

Advanced cloud-based bioinformatics platform designed for the automated analysis, interpretation, and classification of somatic variants in oncology. Through an integrated environment, the system evaluates clinical evidence in real time, automates classification in accordance with AMP/ASCO/CAP guidelines, and provides access to currently active clinical trials. Detailed description Operating principle End-to-end cloud-based solution for the clinical interpretation…
Qiagen
Next Generation Sequencing (NGS)

SeqOne Genomics – Somatic

SeqOne is a bioinformatics platform for NGS data analysis in precision oncology, designed to detect, prioritise and interpret somatic variants and generate actionable clinical reports from raw sequencing data. It helps laboratories and healthcare professionals accelerate the interpretation of NGS data through an end-to-end workflow. Detailed description Operating principle SeqOne Genomics is a genomic data…
SeqOne
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Next Generation Sequencing (NGS)